Oncotargets and Therapy Dovepress Dovepress Long Noncoding Rna Ccat2 Promotes Breast Tumor Growth by Regulating the Wnt Signaling Pathway

In addition to protein-coding genes, the human genome makes a large amount of noncoding RNAs, including microRNAs and long noncoding RNAs (lncRNAs). Emerging evidence indicates that lncRNAs could have a critical role in the regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis. The lncRNA CCAT2 is dysregulated in several cancers such as colon cancer, non-small cell lung cancer, esophageal squamous cell carcinoma, gastric cancer, and breast cancer; however, the contributions of CCAT2 to breast cancer remain largely unknown. In the current paper, we first confirmed the high expression level of CCAT2 in breast cancer tissues and breast cancer cell lines by reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay, and we further analyzed the relationship between CCAT2 expression and clinical prognostic factors. Also, the biological function of CCAT2 was explored and the results showed silencing of CCAT2 could suppress cell growth in vitro and tumor formation in vivo. Finally, our results revealed that the abnormal expression of CCAT2 could influence the Wnt signaling pathway. In conclusion, lncRNA CCAT2 might be considered as a novel molecule involved in breast cancer development, which provides a potential therapeutic target for breast cancer.

[1]  A. Mannermaa,et al.  Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival , 2015, BMC Cancer.

[2]  U. Gezer,et al.  Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease , 2015, Front. Genet..

[3]  Xu Wang,et al.  Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study , 2015, Tumor Biology.

[4]  J. Lewis-Wambi,et al.  Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA , 2015, Breast Cancer Research.

[5]  Lin Xu,et al.  Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma , 2015, Tumor Biology.

[6]  Jiong Wu,et al.  Role of BC040587 as a predictor of poor outcome in breast cancer , 2014, Cancer Cell International.

[7]  Zhidong Lv,et al.  CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. , 2014, International journal of clinical and experimental pathology.

[8]  Françoise Argoul,et al.  Wavelet-based multifractal analysis of dynamic infrared thermograms to assist in early breast cancer diagnosis , 2014, Front. Physiol..

[9]  Rong Yin,et al.  CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer , 2014, Tumor Biology.

[10]  Y. Mo,et al.  Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) , 2014, Cell Death and Disease.

[11]  J. Foekens,et al.  CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations , 2013, Oncotarget.

[12]  J. Foekens,et al.  CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.

[13]  D. Dornan,et al.  miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2013, PloS one.

[14]  D. Glavač,et al.  Long Non-Coding RNA in Cancer , 2013, International journal of molecular sciences.

[15]  L. Kuhn,et al.  Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy , 2012, Tumor Biology.

[16]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[17]  M. Mourtada-Maarabouni,et al.  GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer , 2009, Oncogene.

[18]  Long Hua,et al.  Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. , 2015, International journal of clinical and experimental pathology.

[19]  Y. Zhang,et al.  Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1. , 2015, Neoplasma.

[20]  B. Leyland-Jones,et al.  Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness. , 2014, Neoplasia.

[21]  R. Nusse,et al.  Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.